212 related articles for article (PubMed ID: 22114491)
1. Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells.
Mura S; Hillaireau H; Nicolas J; Le Droumaguet B; Gueutin C; Zanna S; Tsapis N; Fattal E
Int J Nanomedicine; 2011; 6():2591-605. PubMed ID: 22114491
[TBL] [Abstract][Full Text] [Related]
2. Compared in vivo toxicity in mice of lung delivered biodegradable and non-biodegradable nanoparticles.
Aragao-Santiago L; Hillaireau H; Grabowski N; Mura S; Nascimento TL; Dufort S; Coll JL; Tsapis N; Fattal E
Nanotoxicology; 2016; 10(3):292-302. PubMed ID: 26573338
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells.
Grabowski N; Hillaireau H; Vergnaud J; Santiago LA; Kerdine-Romer S; Pallardy M; Tsapis N; Fattal E
Int J Pharm; 2013 Oct; 454(2):686-94. PubMed ID: 23747506
[TBL] [Abstract][Full Text] [Related]
4. Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages.
Grabowski N; Hillaireau H; Vergnaud J; Tsapis N; Pallardy M; Kerdine-Römer S; Fattal E
Int J Pharm; 2015 Mar; 482(1-2):75-83. PubMed ID: 25448553
[TBL] [Abstract][Full Text] [Related]
5. Surface-Modified Biodegradable Nanoparticles' Impact on Cytotoxicity and Inflammation Response on a Co-Culture of Lung Epithelial Cells and Human-Like Macrophages.
Grabowski N; Hillaireau H; Vergnaud-Gauduchon J; Nicolas V; Tsapis N; Kerdine-Römer S; Fattal E
J Biomed Nanotechnol; 2016 Jan; 12(1):135-46. PubMed ID: 27301179
[TBL] [Abstract][Full Text] [Related]
6. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
[TBL] [Abstract][Full Text] [Related]
8. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
[TBL] [Abstract][Full Text] [Related]
9. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
[TBL] [Abstract][Full Text] [Related]
10. Influence of the surface charge of PLGA nanoparticles on their in vitro genotoxicity, cytotoxicity, ROS production and endocytosis.
Platel A; Carpentier R; Becart E; Mordacq G; Betbeder D; Nesslany F
J Appl Toxicol; 2016 Mar; 36(3):434-44. PubMed ID: 26487569
[TBL] [Abstract][Full Text] [Related]
11. Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles.
Guo C; Gemeinhart RA
Eur J Pharm Biopharm; 2008 Oct; 70(2):597-604. PubMed ID: 18602994
[TBL] [Abstract][Full Text] [Related]
12. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
13. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization.
Surassmo S; Saengkrit N; Ruktanonchai UR; Suktham K; Woramongkolchai N; Wutikhun T; Puttipipatkhachorn S
Colloids Surf B Biointerfaces; 2015 Jun; 130():229-36. PubMed ID: 25937384
[TBL] [Abstract][Full Text] [Related]
14. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity.
Yan F; Zhang C; Zheng Y; Mei L; Tang L; Song C; Sun H; Huang L
Nanomedicine; 2010 Feb; 6(1):170-8. PubMed ID: 19447200
[TBL] [Abstract][Full Text] [Related]
15. Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy.
Nguyen J; Steele TW; Merkel O; Reul R; Kissel T
J Control Release; 2008 Dec; 132(3):243-51. PubMed ID: 18619502
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
Zeng P; Xu Y; Zeng C; Ren H; Peng M
Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells.
Mura S; Hillaireau H; Nicolas J; Kerdine-Römer S; Le Droumaguet B; Deloménie C; Nicolas V; Pallardy M; Tsapis N; Fattal E
Biomacromolecules; 2011 Nov; 12(11):4136-43. PubMed ID: 21981120
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes.
Cosco D; Federico C; Maiuolo J; Bulotta S; Molinaro R; Paolino D; Tassone P; Fresta M
Int J Nanomedicine; 2014; 9():2359-72. PubMed ID: 24876772
[TBL] [Abstract][Full Text] [Related]
19. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
[TBL] [Abstract][Full Text] [Related]
20. Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA.
Dailey LA; Kleemann E; Wittmar M; Gessler T; Schmehl T; Roberts C; Seeger W; Kissel T
Pharm Res; 2003 Dec; 20(12):2011-20. PubMed ID: 14725368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]